Published in Biotechnol Appl Biochem on April 01, 2008
Engineering inclusion bodies for non denaturing extraction of functional proteins. Microb Cell Fact (2008) 1.16
Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells. Microb Cell Fact (2010) 1.10
Learning about protein solubility from bacterial inclusion bodies. Microb Cell Fact (2009) 1.09
Isolation of cell-free bacterial inclusion bodies. Microb Cell Fact (2010) 1.05
Towards revealing the structure of bacterial inclusion bodies. Prion (2009) 0.97
Active protein aggregates produced in Escherichia coli. Int J Mol Sci (2011) 0.86
A Structural Study of CESA1 Catalytic Domain of Arabidopsis Cellulose Synthesis Complex: Evidence for CESA Trimers. Plant Physiol (2015) 0.85
Components of the E. coli envelope are affected by and can react to protein over-production in the cytoplasm. Microb Cell Fact (2009) 0.85
Influence of pH control in the formation of inclusion bodies during production of recombinant sphingomyelinase-D in Escherichia coli. Microb Cell Fact (2014) 0.79
Screening and identification of genetic loci involved in producing more/denser inclusion bodies in Escherichia coli. Microb Cell Fact (2013) 0.78
A single freeze-thawing cycle for highly efficient solubilization of inclusion body proteins and its refolding into bioactive form. Microb Cell Fact (2015) 0.77
Production of a recombinant phospholipase A2 in Escherichia coli using resonant acoustic mixing that improves oxygen transfer in shake flasks. Microb Cell Fact (2017) 0.75
Production of nonclassical inclusion bodies from which correctly folded protein can be extracted. Biotechnol Prog (2005) 1.46
Effect of ordering of PtCu₃ nanoparticle structure on the activity and stability for the oxygen reduction reaction. Phys Chem Chem Phys (2014) 1.38
Improved determination of plasmid copy number using quantitative real-time PCR for monitoring fermentation processes. Microb Cell Fact (2008) 1.32
Obstacles and pitfalls in the PEGylation of therapeutic proteins. Curr Opin Drug Discov Devel (2008) 1.27
Engineering inclusion bodies for non denaturing extraction of functional proteins. Microb Cell Fact (2008) 1.16
Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method. Int J Pharm (2004) 0.93
Influence of the protein oligomericity on final yield after affinity tag removal in purification of recombinant proteins. J Chromatogr A (2005) 0.93
High expression of green fluorescent protein in Pichia pastoris leads to formation of fluorescent particles. J Biotechnol (2004) 0.89
Identification of the heparin-binding domain of TNF-alpha and its use for efficient TNF-alpha purification by heparin-Sepharose affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.87
Constitutive versus thermoinducible expression of heterologous proteins in Escherichia coli based on strong PR,PL promoters from phage lambda. Biotechnol Bioeng (2003) 0.87
Attachment of histidine tags to recombinant tumor necrosis factor-alpha drastically changes its properties. ScientificWorldJournal (2002) 0.83
Zinc bioaccumulation in a terrestrial invertebrate fed a diet treated with particulate ZnO or ZnCl2 solution. Toxicology (2009) 0.82
Hindered disulfide bonds to regulate release rate of model drug from mesoporous silica. ACS Appl Mater Interfaces (2013) 0.80
Zinc-decorated silica-coated magnetic nanoparticles for protein binding and controlled release. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.78
Gene Expression Profiling of Recombinant Protein Producing E. coli at Suboptimal Growth Temperature. Acta Chim Slov (2012) 0.78
Vitrification from solution in restricted space: formation and stabilization of amorphous nifedipine in a nanoporous silica xerogel carrier. Int J Pharm (2007) 0.78
Improvement of potential therapeutic value of tumor necrosis-alpha (TNF-alpha) by charge modulation in the tip region. Eur Cytokine Netw (2005) 0.78
Beta-lactamase reporter system for selecting high-producing yeast clones. Biotechniques (2008) 0.78
Novel hybrid silica xerogels for stabilization and controlled release of drug. Int J Pharm (2006) 0.77
Amplified light scattering and emission of silver and silver core-silica shell particles. J Colloid Interface Sci (2007) 0.77
Thermal stability of the WHO international standard of interferon alpha 2b (IFN-alpha 2b): application of new reporter gene assay for IFN-alpha 2b potency determinations. J Immunol Methods (2006) 0.77
Correlations between in vitro potency of polyethylene glycol-protein conjugates and their chromatographic behavior. Anal Biochem (2009) 0.76
Sulphured Polyacrylonitrile Composite Analysed by in operando UV-Visible Spectroscopy and 4-electrode Swagelok Cell. Acta Chim Slov (2016) 0.75
In situ recording of particle network formation in liquids by ion conductivity measurements. J Am Chem Soc (2011) 0.75
New assay for quantification of PEGylated proteins during in vitro permeability studies. Acta Chim Slov (2014) 0.75
Increase of electrodeposited catalyst stability via plasma grown vertically oriented graphene nanoparticle movement restriction. Chem Commun (Camb) (2017) 0.75
Carbon black nanoparticles film electrode prepared by using substrate-induced deposition approach. Anal Chim Acta (2008) 0.75